Fukunaga K - Search Results

1

Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice.

Wang H, Fukunaga K, Cheng A, Wang Y, Arimura N, Yoshino H, Sasaki T, Kawahata I. Wang H, et al. Among authors: fukunaga k. J Pharmacol Sci. 2023 May;152(1):30-38. doi: 10.1016/j.jphs.2023.02.008. Epub 2023 Mar 11. J Pharmacol Sci. 2023. PMID: 37059489 Free article.

2

Akt is a molecular target for signal transduction therapy in brain ischemic insult.

Fukunaga K, Kawano T. Fukunaga K, et al. J Pharmacol Sci. 2003 Aug;92(4):317-27. doi: 10.1254/jphs.92.317. J Pharmacol Sci. 2003. PMID: 12939516 Free article. Review.

3

Transcriptional regulation of neuronal genes and its effect on neural functions: expression and function of forkhead transcription factors in neurons.

Fukunaga K, Ishigami T, Kawano T. Fukunaga K, et al. J Pharmacol Sci. 2005 Jul;98(3):205-11. doi: 10.1254/jphs.fmj05001x3. Epub 2005 Jul 9. J Pharmacol Sci. 2005. PMID: 16006742 Free article. Review.

4

Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model.

Sasaki T, Han F, Shioda N, Moriguchi S, Kasahara J, Ishiguro K, Fukunaga K. Sasaki T, et al. Among authors: fukunaga k. Brain Res. 2006 Sep 7;1108(1):98-106. doi: 10.1016/j.brainres.2006.06.009. Epub 2006 Jul 14. Brain Res. 2006. PMID: 16843447

5

Cardioprotection by vanadium compounds targeting Akt-mediated signaling.

Bhuiyan MS, Fukunaga K. Bhuiyan MS, et al. Among authors: fukunaga k. J Pharmacol Sci. 2009 May;110(1):1-13. doi: 10.1254/jphs.09r01cr. Epub 2009 May 8. J Pharmacol Sci. 2009. PMID: 19423951 Free article. Review.

6

Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: proteins interacting with the third cytoplasmic loop of dopamine D2 and D3 receptors.

Shioda N, Takeuchi Y, Fukunaga K. Shioda N, et al. Among authors: fukunaga k. J Pharmacol Sci. 2010;114(1):25-31. doi: 10.1254/jphs.10r02fm. Epub 2010 Aug 12. J Pharmacol Sci. 2010. PMID: 20716856 Free article. Review.

7

Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.

Moriguchi S, Yabuki Y, Fukunaga K. Moriguchi S, et al. Among authors: fukunaga k. J Neurochem. 2012 Feb;120(4):541-51. doi: 10.1111/j.1471-4159.2011.07608.x. Epub 2012 Jan 6. J Neurochem. 2012. PMID: 22136399 Free article.

8

Novel cognitive enhancer ST101 enhances acetylcholine release in mouse dorsal hippocampus through T-type voltage-gated calcium channel stimulation.

Yamamoto Y, Shioda N, Han F, Moriguchi S, Fukunaga K. Yamamoto Y, et al. Among authors: fukunaga k. J Pharmacol Sci. 2013;121(3):212-26. doi: 10.1254/jphs.12233fp. Epub 2013 Mar 1. J Pharmacol Sci. 2013. PMID: 23449490 Free article.

9

FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity.

Shioda N, Yabuki Y, Kobayashi Y, Onozato M, Owada Y, Fukunaga K. Shioda N, et al. Among authors: fukunaga k. J Biol Chem. 2014 Jul 4;289(27):18957-65. doi: 10.1074/jbc.M113.527341. Epub 2014 May 22. J Biol Chem. 2014. PMID: 24855640 Free PMC article.

10

The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis.

Fukunaga K, Shinoda Y, Tagashira H. Fukunaga K, et al. J Pharmacol Sci. 2015 Jan;127(1):36-41. doi: 10.1016/j.jphs.2014.12.012. Epub 2014 Dec 24. J Pharmacol Sci. 2015. PMID: 25704016 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,414 results

Search Page

Filters